Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECIOUS trial in elderly patients with acute stroke
NL-OMON50714Phase 3Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metoclopramide, ceftriaxone and acetaminophen in stroke, sponsored by University Medical Center Utrecht. Primary endpoint: Modified Rankin Scale at 90 days. Started Apr 2016; status: active, not recruiting.
02
Drugs
metoclopramideceftriaxoneacetaminophen
03
Conditions
stroke
Beyond the preview
Go deeper on NL-OMON50714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50714.